Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Unlocking the Power of Cagrilintide: A Deep Dive Into Dosage Schedules and What to Expect Feast Cagrilintide: What It Is and How It's Being Studied for Weight Loss Retatrutide vs. Tirzepatide: The Next Gen GLP 1 Showdown CagriSema in Clinical Trials: What Patients Should Know Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta Analysis Journal of Clinical Question